XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more
XOMA is expected to report earnings to rise 27.61% to 21 cents per share on July 30
Q2'26
Est.
$0.21
Q1'26
Beat
by $0.12
Q4'25
Beat
by $0.37
Q3'25
Beat
by $0.79
Q2'25
Beat
by $0.64
The last earnings report on April 30 showed earnings per share of 16 cents, beating the estimate of 4 cents. With 134.94K shares outstanding, the current market capitalization sits at 741.62M.